Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA;
Oncologist. 2013;18(10):1074-9. doi: 10.1634/theoncologist.2013-0015. Epub 2013 Sep 18.
We investigated the association between body mass index (BMI) at the time of multiple myeloma (MM) diagnosis and overall survival in a cohort of patients within the Veterans Health Administration system. We also evaluated the association between weight loss in the year prior to diagnosis and survival.
Prospective analysis was performed on a retrospectively assembled cohort of 2,968 U.S. veterans diagnosed and treated for MM between September 1, 1999, and September 30, 2009, with follow-up information through October 22, 2011. Cox modeling controlling for patient- and disease-related prognostic variables was used to analyze the data.
Underweight patients (BMI <18.5 kg/m2) had increased mortality, whereas patients who were overweight (BMI 25-29.9 kg/m2) and obese (BMI ≥30 kg/m2) had lower mortality compared with healthy-weight patients (BMI 18.5-24.9 kg/m2). Weight loss ≥10% of baseline in the year before diagnosis was also associated with increased mortality and made the association between increased BMI and survival nonsignificant.
Disease-related weight loss may be an important and heretofore unknown indicator of poor prognosis in MM. Assessment of weight loss prior to MM diagnosis should become a standard component of the clinical history in patients with newly diagnosed MM. Further research may identify relationships between disease-related weight loss and currently used prognostic factors in MM, further defining the role of this clinical factor in prognostic stratification.
我们研究了退伍军人健康管理系统中一组多发性骨髓瘤(MM)患者在诊断时的体重指数(BMI)与总生存之间的关系。我们还评估了诊断前一年内体重减轻与生存之间的关系。
对 1999 年 9 月 1 日至 2009 年 9 月 30 日期间接受 MM 诊断和治疗的 2968 名美国退伍军人进行回顾性队列分析,随访信息截至 2011 年 10 月 22 日。使用 Cox 模型控制患者和疾病相关预后变量来分析数据。
体重不足患者(BMI<18.5 kg/m2)死亡率增加,而超重患者(BMI 25-29.9 kg/m2)和肥胖患者(BMI≥30 kg/m2)死亡率低于体重正常患者(BMI 18.5-24.9 kg/m2)。诊断前一年内体重减轻≥10%基线也与死亡率增加相关,并使 BMI 增加与生存之间的关系变得不显著。
与疾病相关的体重减轻可能是 MM 预后不良的一个重要且未知的指标。在诊断 MM 之前评估体重减轻应成为新诊断 MM 患者临床病史的标准组成部分。进一步的研究可能会确定与疾病相关的体重减轻与 MM 中目前使用的预后因素之间的关系,从而进一步确定这一临床因素在预后分层中的作用。